A rigorous exploration of anal HPV genotypes using a next ‐generation sequencing (NGS) approach in HIV‐infected men who have sex with men at risk for developing anal cancer
ConclusionNGS ‐based approach is more accurate than PCR‐based HPV testing for identifying HIV+ MSM at risk for developing AC. We raise the concern regarding the efficacy of current HPV vaccines for preventing AC in this high‐risk population.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Chandrika J. Piyathilake,
Suguna Badiga,
Ranjit Kumar,
Michael R. Crowley,
Greer A. Burkholder,
James L. Raper Tags: ORIGINAL RESEARCH Source Type: research
More News: Anal Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Cytology | Genital Warts | Laboratory Medicine | Sexual Abuse | Vaccines